The SODyssey: superoxide dismutases from biochemistry, through proteomics, to oxidative stress, aging and nutraceuticals

References

• Kresge N, Simoni RD, Hill RL. Forty years of superoxide dismutase research: the work of Irwin Fridovich. J. Biol. Chem.281(22), 17–19 (2006).
   Google Scholar
• McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem.244(22), 6049–6055 (1969).
   PubMed Web of Science ®Google Scholar
• Bannister JV, Bannister WH, Rotilio G. Aspects of the structure, function, and applications of superoxide dismutase. CRC Crit. Rev. Biochem.22(2), 111–180 (1987).
   PubMed Web of Science ®Google Scholar
• Miller AF. Superoxide dismutases: active sites that save, but a protein that kills. Curr. Opin. Chem. Biol.8(2), 162–168 (2004).
   PubMed Web of Science ®Google Scholar
• Perry JJP, Shin DS, Getzoff ED, Tainer JA. The structural biochemistry of the superoxide dismutases. Biochim. Biophys. Acta1804, 245–262 (2010).
   PubMed Web of Science ®Google Scholar
• Bannister WH, Bannister JV. Isolation and characterization of superoxide dismutase: a personal history and tribute to Joe McCord and Irwin Fridovich. Free Radic. Biol. Med.5(5–6), 371–376 (1988).
   PubMed Web of Science ®Google Scholar
• Mann T, Keilin D. Haemocuprein and hepatocuprein, copper-protein compounds of blood and liver in mammals. Proc. R. Soc. London Ser. B.126(844), 303–315 (1938).
   Google Scholar
• Porter H, Folch J, Cerebrocuprein I. A copper-containing protein isolated from brain. J. Neurochem.1(3), 260–271 (1957).
   PubMed Web of Science ®Google Scholar
• Carrico RJ, Deutsch HF. Isolation of human hepatocuprein and cerebrocuprein. Their identity with erythrocuprein. J. Biol. Chem.244(22), 6087–6093 (1969).
   PubMed Web of Science ®Google Scholar
• Keele BB Jr, McCord JM, Fridovich I. Superoxide dismutase from Escherichia coli B. A new manganese-containing enzyme. J. Biol. Chem.245(22), 6176–6181 (1970).
   PubMed Web of Science ®Google Scholar
• Yost FJ, Fridovich I. An iron-containing superoxide dismutase from Escherichia coli.J. Biol. Chem.248, 4905 (1973).
   PubMed Web of Science ®Google Scholar
• Fridovich I. Superoxide dismutases. Adv. Enzymol.41, 35–97 (1974).
   PubMedGoogle Scholar
• Bray RC, Cockle SA, Fielden EM et al. Reduction and inactivation of superoxide dismutase by hydrogen peroxide. Biochem. J.139(1), 43–48 (1974).
   PubMed Web of Science ®Google Scholar
• Misra HP, Fridovich I. Inhibition of superoxide dismutase by azide. Arch. Biochem. Biophys.189, 317 (1978).
   PubMed Web of Science ®Google Scholar
• Knowles PF, Gibson JF, Pick FM, Bray RC. Electron-spin-resonance evidence for enzymic reduction of oxygen to a free radical, the superoxide ion. Biochem. J.111(1), 53–58 (1969).
   PubMed Web of Science ®Google Scholar
• Weisiger RA, Fridovich I. Superoxide dismutase. Organelle specificity. J. Biol. Chem.248(10), 3582–3592 (1973).
   PubMed Web of Science ®Google Scholar
• McCord JM, Keele BB Jr, Fridovich I. An enzyme-based theory of obligate anaerobiosis: the physiological function of superoxide dismutase. Proc. Natl Acad. Sci. USA68(5), 1024–1027 (1971).
   PubMed Web of Science ®Google Scholar
• Bell GR. Studies on electron transfer system in Desulfovibrio: purification of hydrogenase. catalase and superoxide dismutase. PhD thesis, University of Georgia, Athens, Greece, 206–208 (1973).
   Google Scholar
• Hewitt J, Morris JG. Superoxide dismutase in some obligately anaerobic bacteria. FEBS Lett.50(3), 315–315 (1975).
   PubMed Web of Science ®Google Scholar
• Norrod P, Morse SA. Absence of superoxide dismutase in some strains of Neisseria gonorrhoeae.Biochem. Biophys. Res. Commun.90(4), 1287–1294 (1979).
   PubMed Web of Science ®Google Scholar
• Richardson JS, Thomas KA, Rubin BH, Richardson DC. Crystal structure of bovine Cu,Zn superoxide dismutase at 3Å resolution: chain tracing and metal ligands. Proc. Natl Acad. Sci. USA72(4), 1349–1353 (1975).
   PubMed Web of Science ®Google Scholar
• Getzoff ED, Tainer JA, Weiner PK et al. Electrostatic recognition between superoxide and copper, zinc superoxide dismutase. Nature306(5940), 287–290 (1983).
   PubMed Web of Science ®Google Scholar
• Tainer JA, Getzoff ED, Richardson JS, Richardson DC. Structure and mechanism of copper, zinc superoxide dismutase. Nature306(5940), 284–287 (1983).
   PubMed Web of Science ®Google Scholar
• Borgstahl GE, Parge HE, Hickey MJ et al. The structure of human mitochondrial manganese superoxide dismutase reveals a novel tetrameric interface of two 4-helix bundles. Cell71(1), 107–118 (1992).
   PubMed Web of Science ®Google Scholar
• Lynch RE, Cole BC. Mycoplasma pneumoniae: a prokaryote which consumes oxygen and generates superoxide but which lacks superoxide dismutase. Biochem. Biophys. Res. Commun.96(1), 98–105 (1980).
   Google Scholar
• Carlioz A, Touati D. Isolation of superoxide dismutase mutants in Escherichia coli: is superoxide dismutase necessary for aerobic life? EMBO J.5, 623–630 (1986).
   PubMed Web of Science ®Google Scholar
• Parge HE, Hallewell RA, Tainer JA. Atomic structures of wild-type and thermostable mutant recombinant human Cu,Zn superoxide dismutase. Proc. Natl Acad. Sci. USA89, 6109–6113 (1992).
   PubMed Web of Science ®Google Scholar
• Miao L, St Clair DK. Regulation of superoxide dismutase genes: implications in disease. Free Radic. Biol. Med.47(4), 344–356 (2009).
   PubMed Web of Science ®Google Scholar
• Barondeau DP, Kassmann CJ, Bruns CK et al. Nickel superoxide dismutase structure and mechanism. Biochemistry43(25), 8038–8047 (2004).
   PubMed Web of Science ®Google Scholar
• Wuerges J, Lee JW, Yim YI, Yim HS, Kang SO, Djinovic Carugo K. Crystal structure of nickel-containing superoxide dismutase reveals another type of active site. Proc. Natl Acad. Sci. USA101(23), 8569–8574 (2004).
   PubMed Web of Science ®Google Scholar
• Herbst RW, Guce A, Bryngelson PA et al. Role of conserved tyrosine residues in NiSOD catalysis: a case of convergent evolution. Biochemistry48(15), 3354–3369 (2009).
   PubMed Web of Science ®Google Scholar
• Fridovich I. The biology of oxygen radicals. Science201(4359), 875–880 (1978).
   PubMed Web of Science ®Google Scholar
• McCord JM, Fridovich I. The biology and pathology of oxygen radicals. Ann. Intern. Med.89(1), 122–127 (1978).
   PubMed Web of Science ®Google Scholar
• Eastgate J, Moreb J, Nick HS et al. A role for manganese superoxide dismutase in radioprotection of hematopoietic stem cells by interleukin-1. Blood81, 639–646 (1993).
   PubMed Web of Science ®Google Scholar
• Akashi M, Hachiya M, Paquette RL et al. Irradiation increases manganese superoxide dismutase mRNA levels in human fibroblasts. Possible mechanisms for its accumulation. J. Biol. Chem.270, 15864–15869 (1995).
   PubMed Web of Science ®Google Scholar
• Fujii J, Taniguchi N. Phorbol ester induces manganese-superoxide dismutase in tumor necrosis factor resistant cells. J. Biol. Chem.266, 23142–23146 (1991).
   PubMed Web of Science ®Google Scholar
• Harris CA, Derbin KS, Hunte-McDonough B et al. Manganese superoxide dismutase is induced by IFN-γ in multiple cell types. Synergistic induction by IFN-γ and tumor necrosis factor or IL-1. J. Immunol.147, 149–154 (1991).
   PubMed Web of Science ®Google Scholar
• Wong GH, Elwell JH, Oberley LW, Goeddel DV. Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell58, 923–931 (1988).
   Web of Science ®Google Scholar
• Wong GH, Goeddel DV. Induction of manganous superoxide dismutase by tumor necrosis factor: possible protective mechanism. Science242, 941–944 (1988).
   PubMed Web of Science ®Google Scholar
• Visner GA, Dougall WC, Wilson JM et al. Regulation of manganese superoxide dismutase by lipopolysaccharide, interleukin-1, and tumor necrosis factor. Role in the acute inflammatory response. J. Biol. Chem.265, 2856–2864 (1990).
   PubMed Web of Science ®Google Scholar
• Dougall WC, Nick HS. Manganese superoxide dismutase: a hepatic acute phase protein regulated by interleukin-6 and glucocorticoids. Endocrinology129, 2376–2384 (1991).
   PubMed Web of Science ®Google Scholar
• Pasini EM, Kirkegaard M, Mortensen P et al. In-depth analysis of the membrane and cytosolic proteome of red blood cells. Blood108, 791–801 (2006).
   PubMed Web of Science ®Google Scholar
• Roux-Dalvai F, Gonzalez de Peredo A, Simó C et al. Extensive analysis of the cytoplasmic proteome of human erythrocytes using the peptide ligand library technology and advanced mass spectrometry. Mol. Cell Proteomics7(11), 2254–2269 (2008).
   PubMed Web of Science ®Google Scholar
• Goodman SR, Kurdia A, Ammann L et al. The human red blood cell proteome and interactome. Exp. Biol. Med.232, 1391–1408 (2007).
   PubMed Web of Science ®Google Scholar
• D’Alessandro A, Righetti PG, Zolla L. The red blood cell proteome and interactome: an update. J. Proteome Res.9(1), 144–163 (2010).
   PubMed Web of Science ®Google Scholar
• Winterbourn CC, Hawkins RE, Brian M, Carrell RW. The estimation of red cell superoxide dismutase activity. J. Lab. Clin. Med.85(2), 337–341 (1975).
   PubMed Web of Science ®Google Scholar
• Sutton HC, Roberts PB, Winterbourn CC. The rate of reaction of superoxide radical ion with oxyhaemoglobin and methaemoglobin. Biochem. J.155(3), 503–510 (1976).
   PubMed Web of Science ®Google Scholar
• Bartosz G, Fried R, Grzelińska E, Leyko W. Effect of hyperoxide radicals on bovine-erythrocyte membrane. Eur. J. Biochem.73(1), 261–264 (1977).
   PubMedGoogle Scholar
• Watanabe H, Kobayashi A, Yamamoto T et al. Alterations of human erythrocyte membrane fluidity by oxygen-derived free radicals and calcium. Free Radic. Biol. Med.8(6), 507–514 (1990).
   PubMed Web of Science ®Google Scholar
• Aslan R, Sekeroğlu MR, Tarakçioğlu M, Köylü H. Investigation of malondialdehyde formation and antioxidant enzyme activity in stored blood. Haematologia28(4), 233–237 (1997).
   PubMedGoogle Scholar
• Korgun DK, Bilmen S, Yesilkaya A. Alterations in the erythrocyte antioxidant system of blood stored in blood bags. Res. Commun. Mol. Pathol. Pharmacol.109(5–6), 357–363 (2001).
   PubMedGoogle Scholar
• Kanias T, Acker JP. Biopreservation of red blood cells – the struggle with hemoglobin oxidation. FEBS J.277(2), 343–356 (2010).
   PubMed Web of Science ®Google Scholar
• Racek J, Herynkova R, Holecek V et al. Influence of antioxidants on the quality of stored blood. Vox. Sang.72, 16–19 (1997).
   PubMed Web of Science ®Google Scholar
• Högman CF, de Verdier CH, Ericson A et al. Effects of oxygen on red cells during liquid storage at +4 degrees C. Vox. Sang.51(1), 27–34 (1986).
   PubMed Web of Science ®Google Scholar
• Yoshida T, AuBuchon JP, Tryzelaar L et al. Extended storage of red blood cells under anaerobic conditions. Vox. Sang.92, 22–31 (2007).
   PubMed Web of Science ®Google Scholar
• D’Amici GM, Rinalducci S, Zolla L. Proteomic analysis of RBC membrane protein degradation during blood storage. J. Prot. Res.6, 3242–3255 (2007).
   PubMed Web of Science ®Google Scholar
• Mattei JF, Baeteman MA, Baret A et al. Erythrocyte superoxide dismutase and redox enzymes in trisomy 21. Acta Paediatr. Scand.71, 589 (1982).
   PubMed Web of Science ®Google Scholar
• Sinet PM, Lavelle F, Michelson AM, Jerome H. Superoxide dismutase activities of blood platelets in trisomy 21. Biochem. Biophys. Res. Commun.67, 904 (1975).
   PubMed Web of Science ®Google Scholar
• Feaster WW, Kwok LW, Epstein CJ. Dosage effects for superoxide dismutase-1 in nucleated cells aneuploid for chromosome 21. Am. J. Hum. Genet.29(6), 563–570 (1977).
   PubMed Web of Science ®Google Scholar
• Frischer H, Chu LK, Ahmad T, Justice P, Smith GF. Superoxide dismutase and glutathione peroxidase abnormalities in erythrocytes and lymphoid cells in Down’s syndrome. Prog. Clin. Biol. Res.55, 269–289 (1981).
   PubMedGoogle Scholar
• Koster MP, Pennings JL, Imholz S et al. Bead-based multiplexed immunoassays to identify new biomarkers in maternal serum to improve first trimester Down syndrome screening. Prenat. Diagn.29(9), 857–862 (2009).
   PubMed Web of Science ®Google Scholar
• Shin JH, Krapfenbauer K, Lubec G. Mass-spectrometrical analysis of proteins encoded on chromosome 21 in human fetal brain. Amino Acids31(4), 435–447 (2006).
   PubMed Web of Science ®Google Scholar
• Gulesserian T, Engidawork E, Fountoulakis M, Lubec G. Antioxidant proteins in fetal brain: superoxide dismutase-1 (SOD-1) protein is not overexpressed in fetal Down syndrome. J. Neural Transm. Suppl.61, 71–84 (2001).
   PubMedGoogle Scholar
• Krapfenbauer K, Engidawork E, Cairns N et al. Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders. Brain Res.967(1–2), 152–160 (2003).
   PubMed Web of Science ®Google Scholar
• Lehtinen MK, Bonni A. Modeling oxidative stress in the central nervous system. Curr. Mol. Med.6(8), 871–881 (2006).
   PubMed Web of Science ®Google Scholar
• Gardiner J, Barton D, Overall R, Marc J. Neurotrophic support and oxidative stress: converging effects in the normal and diseased nervous system. Neuroscientist15(1), 47–61 (2009).
   PubMed Web of Science ®Google Scholar
• Perry JJ, Shin DS, Tainer JA. Amyotrophic lateral sclerosis. Adv. Exp. Med. Biol.685, 9–20 (2010).
   PubMed Web of Science ®Google Scholar
• Deng HX, Hentati A, Tainer JA et al. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science261(5124), 1047–1051 (1993).
   PubMed Web of Science ®Google Scholar
• Wroe R, Wai-Ling Butler A, Andersen PM et al. ALSOD: the Amyotrophic Lateral Sclerosis Online Database. Amyotroph Lateral Scler.9(4), 249–250 (2008).
   PubMed Web of Science ®Google Scholar
• Kabuta T, Kinugawa A, Tsuchiya Y et al. Familial amyotrophic lateral sclerosis-linked mutant SOD1 aberrantly interacts with tubulin. Biochem. Biophys. Res. Commun.387, 121–126 (2009).
   PubMed Web of Science ®Google Scholar
• Steinacker P, Hawlik A, Lehnert S et al. Neuroprotective function of cellular prion protein in a mouse model of amyotrophic lateral sclerosis. Am. J. Pathol.176(3), 1409–1420 (2010).
   PubMed Web of Science ®Google Scholar
• Zhai J, Ström AL, Kilty R et al. Proteomic characterization of lipid raft proteins in amyotrophic lateral sclerosis mouse spinal cord. FEBS J.276(12), 3308–3323 (2009).
   PubMed Web of Science ®Google Scholar
• Bergemalm D, Forsberg K, Srivastava V et al. Superoxide dismutase-1 and other proteins in inclusions from transgenic amyotrophic lateral sclerosis model mice. J. Neurochem.114(2), 408–418 (2010).
   PubMed Web of Science ®Google Scholar
• Baillet A, Chanteperdrix V, Trocmé C et al. The role of oxidative stress in amyotrophic lateral sclerosis and Parkinson’s disease. Neurochem Res.35(10), 1530–1537 (2010).
   PubMed Web of Science ®Google Scholar
• Bonnefont-Rousselot D, Lacomblez L, Jaudon M et al. Blood oxidative stress in amyotrophic lateral sclerosis. J. Neurol. Sci.178(1), 57–62 (2000).
   PubMed Web of Science ®Google Scholar
• Shi P, Wei Y, Zhang J et al. Mitochondrial dysfunction is a converging point of multiple pathological pathways in amyotrophic lateral sclerosis. J. Alzheimers Dis.20(2), 311–324 (2010).
   PubMed Web of Science ®Google Scholar
• Valentine JS, Doucette PA, Zittin Potter S. Copper–zinc superoxide dismutase and amyotrophic lateral sclerosis. Annu. Rev. Biochem.74, 563–593 (2005).
   PubMed Web of Science ®Google Scholar
• Hinerfeld D, Traini MD, Weinberger RP et al. Endogenous mitochondrial oxidative stress: neurodegeneration, proteomic analysis, specific respiratory chain defects, and efficacious antioxidant therapy in superoxide dismutase 2 null mice. J. Neurochem.88(3), 657–667 (2004).
   PubMed Web of Science ®Google Scholar
• Smith RA, Miller TM, Yamanaka K et al. Antisense oligonucleotide therapy for neurodegenerative disease. J. Clin. Invest.116(8), 2290–2296 (2006).
   PubMed Web of Science ®Google Scholar
• Castegna A, Aksenov M, Aksenova M et al. Proteomic identification of oxidatively modified proteins in Alzheimer’s disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1. Free Radic. Biol. Med.33(4), 562–571 (2002).
   PubMed Web of Science ®Google Scholar
• Butterfield DA, Boyd-Kimball D. Amyloid β-peptide(1–42) contributes to the oxidative stress and neurodegeneration found in Alzheimer disease brain. Brain Pathol.14(4), 426–432 (2004).
   PubMed Web of Science ®Google Scholar
• Butterfield DA, Perluigi M, Sultana R. Oxidative stress in Alzheimer’s disease brain: new insights from redox proteomics. Eur. J. Pharmacol.545(1), 39–50 (2006).
   PubMed Web of Science ®Google Scholar
• Opii WO, Joshi G, Head E et al. Proteomic identification of brain proteins in the canine model of human aging following a long-term treatment with antioxidants and a program of behavioral enrichment: relevance to Alzheimer’s disease. Neurobiol. Aging29(1), 51–70 (2008).
   PubMed Web of Science ®Google Scholar
• Tsang AH, Chung KK. Oxidative and nitrosative stress in Parkinson’s disease. Biochim. Biophys. Acta1792(7), 643–650 (2009).
   PubMed Web of Science ®Google Scholar
• Guo J, Sun Z, Xiao S et al. Proteomic analysis of the cerebrospinal fluid of Parkinson’s disease patients. Cell Res.19(12), 1401–1403 (2009).
   PubMed Web of Science ®Google Scholar
• Sinha A, Srivastava N, Singh S et al. Identification of differentially displayed proteins in cerebrospinal fluid of Parkinson’s disease patients: a proteomic approach. Clin. Chim. Acta400(1–2), 14–20 (2009).
   PubMed Web of Science ®Google Scholar
• Akbostanci MC, Kocatürk PA, Tan FU, Kavas GO. Erythrocyte superoxide dismutase activity differs in clinical subgroups of Parkinson’s disease patients. Acta Neurol. Belg.101(3), 180–183 (2001).
   PubMed Web of Science ®Google Scholar
• Tórsdóttir G, Sveinbjörnsdóttir S, Kristinsson J et al. Ceruloplasmin and superoxide dismutase (SOD1) in Parkinson’s disease: a follow-up study. J. Neurol. Sci.241(1–2), 53–58 (2006).
   PubMed Web of Science ®Google Scholar
• Werner CJ, Heyny-von Haussen R, Mall G, Wolf S. Proteome analysis of human substantia nigra in Parkinson’s disease. Proteome Sci.6, 8 (2008).
   PubMed Web of Science ®Google Scholar
• Basso M, Giraudo S, Corpillo D et al. Proteome analysis of human substantia nigra in Parkinson’s disease. Proteomics4(12), 3943–3952 (2004).
   PubMed Web of Science ®Google Scholar
• Carrillo MC, Minami C, Kitani K et al. Enhancing effect of rasagiline on superoxide dismutase and catalase activities in the dopaminergic system in the rat. Life Sci.67(5), 577–585 (2000).
   PubMed Web of Science ®Google Scholar
• The Huntington’s Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell72(6), 971–983 (1993).
   PubMed Web of Science ®Google Scholar
• Perez-De La Cruz V, Santamaria A. Integrative hypothesis for Huntington’s disease: a brief review of experimental evidence. Physiol. Res.56(5), 513–526 (2007).
   PubMed Web of Science ®Google Scholar
• Sorolla MA, Reverter-Branchat G, Tamarit J et al. Proteomic and oxidative stress analysis in human brain samples of Huntington disease. Free Radic. Biol. Med.45(5), 667–678 (2008).
   PubMed Web of Science ®Google Scholar
• Sorolla MA, Rodríguez-Colman MJ, Tamarit J et al. Protein oxidation in Huntington disease affects energy production and vitamin B6 metabolism. Free Radic. Biol. Med.49(4), 612–621 (2010).
   PubMed Web of Science ®Google Scholar
• Lund-Olesen K. Etiology of multiple sclerosis: role of superoxide dismutase. Med. Hypotheses54(2), 321–322 (2000).
   PubMed Web of Science ®Google Scholar
• Namaki S, Mohsenzadegan M, Mirshafiey A. Superoxide dismutase: a light horizon in treatment of multiple sclerosis. J. Chin. Clin. Med.10(4), 10 (2009).
   Google Scholar
• Zagórski T, Dudek I, Berkan L et al. [Superoxide dismutase (SOD-1) activity in erythrocytes of patients with multiple sclerosis]. Neurol. Neurochir. Pol.25(6), 725–730 (1991).
   PubMedGoogle Scholar
• Dumont D, Noben JP, Raus J et al. Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients. Proteomics4(7), 2117–2124 (2004).
   PubMed Web of Science ®Google Scholar
• Liu S, Bai S, Qin Z et al. Quantitative proteomic analysis of the cerebrospinal fluid of patients with multiple sclerosis. J. Cell Mol. Med.13(8A), 1586–1603 (2009).
   PubMed Web of Science ®Google Scholar
• Stoop MP, Singh V, Dekker LJ et al. Proteomics comparison of cerebrospinal fluid of relapsing remitting and primary progressive multiple sclerosis. PLoS One5(8), e12442 (2010).
   PubMed Web of Science ®Google Scholar
• Prabakaran S, Wengenroth M, Lockstone HE et al. 2-D DIGE analysis of liver and red blood cells provides further evidence for oxidative stress in schizophrenia. J. Proteome Res.6(1), 141–149 (2007).
   PubMed Web of Science ®Google Scholar
• Yao JK, Reddy R, van Kammen DP. Abnormal age-related changes of plasma antioxidant proteins in schizophrenia. Psychiatry Res.97(2–3), 137–151 (2000).
   PubMed Web of Science ®Google Scholar
• Dietrich-Muszalska A, Olas B. Modifications of blood platelet proteins of patients with schizophrenia. Platelets20(2), 90–96 (2009).
   PubMed Web of Science ®Google Scholar
• Zhang XY, Tan YL, Cao LY et al. Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics. Schizophr. Res.81(2–3), 291–300 (2006).
   PubMed Web of Science ®Google Scholar
• Herken H, Gurel A, Selek S et al. Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment. Arch. Med. Res.38(2), 247–252 (2007).
   PubMed Web of Science ®Google Scholar
• Russo AJ. Increased serum Cu/Zn-SOD in individuals with clinical depression normalizes after zinc and antioxidant therapy. Nutr. Met. Insights3, 37–42 (2010).
   PubMedGoogle Scholar
• Selek S, Savas HA, Gergerlioglu HS et al. The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode. J. Affect. Disord.107(1–3), 89–94 (2008).
   PubMed Web of Science ®Google Scholar
• Teyssier JR, Ragot S, Chauvet-Gélinier JC, Trojak B, Bonin B. Expression of oxidative stress-response genes is not activated in the prefrontal cortex of patients with depressive disorder. Psychiatry Res.186(2–3), 244–247 (2010).
   Web of Science ®Google Scholar
• Martins-de-Souza D, Harris LW, Guest PC et al. The role of proteomics in depression research. Eur. Arch. Psychiatry Clin. Neurosci.260(6), 499–506 (2010).
   PubMed Web of Science ®Google Scholar
• Russo AJ. Increased serum Cu/Zn superoxide dismutase in individuals with anxiety. Proteomics Insights3, 49–354 (2010).
   Google Scholar
• Dai Q, Escobar GP, Hakala KW et al. The left ventricle proteome differentiates middle-aged and old left ventricles in mice. J. Proteome Res.7(2), 756–765 (2008).
   PubMed Web of Science ®Google Scholar
• Balestrieri ML, Giovane A, Mancini FP, Napoli C. Proteomics and cardiovascular disease: an update. Curr. Med. Chem.15(6), 555–572 (2008).
   PubMed Web of Science ®Google Scholar
• Ungvari Z, Sonntag WE, Csiszar A. Mitochondria and aging in the vascular system. J Mol Med.88(10), 1021–1027 (2010).
   PubMed Web of Science ®Google Scholar
• Mayr M, Chung YL, Mayr U et al. Proteomic and metabolomic analyses of atherosclerotic vessels from apolipoprotein E-deficient mice reveal alterations in inflammation, oxidative stress, and energy metabolism. Arterioscler. Thromb. Vasc. Biol.25(10), 2135–2142 (2005).
   PubMed Web of Science ®Google Scholar
• Yue TL, Cheng HY, Lysko PG et al. Carvedilol, a new vasodilator and β adrenoceptor antagonist, is an antioxidant and free radical scavenger. J. Pharmacol. Exp. Ther.263(1), 92–98 (1992).
   PubMed Web of Science ®Google Scholar
• Weseler AR, Bast A. Oxidative stress and vascular function: implications for pharmacologic treatments. Curr. Hypertens. Rep.12(3), 154–161 (2010).
   PubMed Web of Science ®Google Scholar
• Adam O, Laufs U. Antioxidative effects of statins. Arch. Toxicol.82, 885–892 (2008).
   PubMed Web of Science ®Google Scholar
• Zamboni P, Galeotti R, Menegatti E et al. Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. J. Neurol. Neurosurg. Psychiatry80(4), 392–399 (2009).
   PubMed Web of Science ®Google Scholar
• Bartolomei I, Salvi F, Galeotti R et al. Hemodynamic patterns of chronic cerebrospinal venous insufficiency in multiple sclerosis. Correlation with symptoms at onset and clinical course. Int. Angiol.29(2), 183–188 (2010).
   PubMed Web of Science ®Google Scholar
• Singh AV, Zamboni P. Anomalous venous blood flow and iron deposition in multiple sclerosis. J. Cereb. Blood Flow Metab.29(12), 1867–1878 (2009).
   PubMed Web of Science ®Google Scholar
• Qiao T, Liu C, Ran F. The impact of gastrocnemius muscle cell changes in chronic venous insufficiency. Eur. J. Vasc. Endovasc. Surg.30(4), 430–436 (2005).
   PubMed Web of Science ®Google Scholar
• Seyfried TN, Shelton LM. Cancer as a metabolic disease. Nutr. Metab.7, 7 (2010).
   Google Scholar
• Warburg O. On the origin of cancer cells. Science123, 309–314 (1956).
   PubMed Web of Science ®Google Scholar
• Seyfried TN, Mukherjee P. Targeting energy metabolism in brain cancer: review and hypothesis. Nutr. Metab.2, 30 (2005).
   Google Scholar
• Chen Y, Cairns R, Papandreou I et al. Oxygen consumption can regulate the growth of tumors, a new perspective on the warburg effect. PLoS One4, e7033 (2009).
   PubMed Web of Science ®Google Scholar
• Wang F, Ogasawara MA, Huang P. Small mitochondria-targeting molecules as anti-cancer agents. Mol. Aspects Med.31(1), 75–92 (2010).
   PubMed Web of Science ®Google Scholar
• Sattler UG, Hirschhaeusera F, Mueller-Klieser WF. Manipulation of glycolysis in malignant tumors: fantasy or therapy? Curr. Med. Chem.17(2), 96–108 (2010).
   PubMed Web of Science ®Google Scholar
• Park D, Dilda PJ. Mitochondria as targets in angiogenesis inhibition. Mol. Aspects Med.31(1), 113–131 (2010).
   PubMed Web of Science ®Google Scholar
• Wang HH, Mao CY, Teng LS, Cao J. Recent advances in heat shock protein-based cancer vaccines. Hepatobillary Pancr. Dis. Int.5, 22–27 (2006).
   PubMedGoogle Scholar
• Park CK, Jung JH, Moon MJ et al. Tissue expression of manganese superoxide dismutase is a candidate prognostic marker for glioblastoma. Oncology77(3–4), 178–181 (2009).
   PubMed Web of Science ®Google Scholar
• Sandoval JA, Hoelz DJ, Woodruff HA et al. Novel peptides secreted from human neuroblastoma: useful clinical tools? J. Pediatr. Surg.41(1), 245–251 (2006).
   PubMed Web of Science ®Google Scholar
• Hurt EM, Thomas SB, Peng B, Farrar WL. Integrated molecular profiling of SOD2 expression in multiple myeloma. Blood109(9), 3953–3962 (2007).
   PubMed Web of Science ®Google Scholar
• Wang Y, Chiu JF. Proteomic approaches in understanding action mechanisms of metal-based anticancer drugs. Met. Based Drugs.2008, 716329 (2008).
   PubMedGoogle Scholar
• Valko M, Rhodes CJ, Moncol J et al. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact.160(1), 1–40 (2006).
   PubMed Web of Science ®Google Scholar
• Kim JW, Nie B, Sahm H et al. Targeted quantitative analysis of superoxide dismutase 1 in cisplatin-sensitive and cisplatin-resistant human ovarian cancer cells. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.878(7–8), 700–704 (2010).
   PubMed Web of Science ®Google Scholar
• Brown DP, Chin-Sinex H, Nie B et al. Targeting superoxide dismutase 1 to overcome cisplatin resistance in human ovarian cancer. Cancer Chemother. Pharmacol.63(4), 723–730 (2009).
   PubMed Web of Science ®Google Scholar
• Squier TC. Oxidative stress and protein aggregation during biological aging. Exp. Gerontol.36(9), 1539–1550 (2001).
   PubMed Web of Science ®Google Scholar
• Colavitti R, Finkel T. Reactive oxygen species as mediators of cellular senescence. IUBMB Life57(4–5), 277–281 (2005).
   PubMed Web of Science ®Google Scholar
• Ahmed S, Passos JF, Birket MJ et al. Telomerase does not counteract telomere shortening but protects mitochondrial function under oxidative stress. J. Cell Sci.121(7), 1046–1053 (2008).
   PubMed Web of Science ®Google Scholar
• Orr WC, Sohal RS. Extension of life-span by overexpression of superoxide dismutase and catalase in Drosophila melanogaster.Science263(5150), 1128–1130 (1994).
   PubMed Web of Science ®Google Scholar
• Sohal RS, Agarwal A, Agarwal S, Orr WC. Simultaneous overexpression of copper- and zinc-containing superoxide dismutase and catalase retards age-related oxidative damage and increases metabolic potential in Drosophila melanogaster. J. Biol. Chem.270(26), 15671–15674 (1995).
   PubMed Web of Science ®Google Scholar
• Kregel KC, Zhang HJ. An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations. Am. J. Physiol. Regul. Integr. Comp. Physiol.292(1), 18–36 (2007).
   PubMed Web of Science ®Google Scholar
• Huang TT, Carlson EJ, Gillespie AM et al. Ubiquitous overexpression of CuZn superoxide dismutase does not extend life span in mice. J. Gerontol. A. Biol. Sci. Med. Sci.55(1), B5–B9 (2000).
   Google Scholar
• Van Remmen H, Ikeno Y, Hamilton M et al. Life-long reduction in Mn-SOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol. Genomics16(1), 29–37 (2003).
   PubMed Web of Science ®Google Scholar
• Page MM, Richardson J, Wiens BE et al. Antioxidant enzyme activities are not broadly correlated with longevity in 14 vertebrate endotherm species. Age (Dordr.)32(2), 255–270 (2010).
   PubMedGoogle Scholar
• Salway KD, Page MM, Faure PA et al. Enhanced protein repair and recycling are not correlated with longevity in 15 vertebrate endotherm species. Age (Dordr.)33(1), 33–47 (2010).
   PubMedGoogle Scholar
• Gomez-Cabrera MC, Domenech E, Viña J. Moderate exercise is an antioxidant: upregulation of antioxidant genes by training. Free Radic. Biol. Med.44(2), 126–131 (2008).
   PubMed Web of Science ®Google Scholar
• Mitteldorf J. Aging is not a process of wear and tear. Rejuvenation Res.13(2–3), 322–326 (2010).
   PubMed Web of Science ®Google Scholar
• Nikolaidis MG, Jamurtas AZ. Blood as a reactive species generator and redox status regulator during exercise. Arch. Biochem. Biophys.490(2), 77–84 (2009).
   PubMed Web of Science ®Google Scholar
• Ristow M, Zarse K. How increased oxidative stress promotes longevity and metabolic health: the concept of mitochondrial hormesis (mitohormesis). Exp. Gerontol.45(6), 410–418 (2010).
   PubMed Web of Science ®Google Scholar
• Cobon GS, Verrills N, Papakostopoulos P et al. The proteomics of aging. Biogerontology3, 133–136 (2002).
   PubMed Web of Science ®Google Scholar
• Franco OH, Karnik K, Osborne G et al. Changing course in aging research: the healthy aging phenotype. Maturitas63(1), 13–19 (2009).
   PubMed Web of Science ®Google Scholar
• Onken B, Driscoll M. Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans healthspan via AMPK, LKB1, and SKN-1. PLoS One5(1), e8758 (2010).
   PubMed Web of Science ®Google Scholar
• Tullet JM, Hertweck M, An JH et al. Direct inhibition of the longevity-promoting factor SKN-1 by insulin-like signaling in C. elegans.Cell132(6), 1025–1038 (2008).
   PubMed Web of Science ®Google Scholar
• Marrades MP, González-Muniesa P, Arteta D et al. Orchestrated downregulation of genes involved in oxidative metabolic pathways in obese vs. lean high-fat young male consumers. J. Physiol. Biochem.67(1), 15–26 (2010).
   PubMed Web of Science ®Google Scholar
• vel Szic KS, Ndlovu MN et al. Nature or nurture: let food be your epigenetic medicine in chronic inflammatory disorders. Biochem. Pharmacol.80(12), 1816–1832 (2010).
   PubMed Web of Science ®Google Scholar
• Ang ET, Tai YK, Lo SQ et al. Neurodegenerative diseases: exercising toward neurogenesis and neuroregeneration. Front Aging Neurosci.2, 25 (2010).
   PubMed Web of Science ®Google Scholar
• Lambert JD, Sang S, Yang CS. Possible controversy over dietary polyphenols: benefits vs risks. Chem. Res. Toxicol.20(4), 583–585 (2007).
   PubMed Web of Science ®Google Scholar
• Huang Z, Zuo L, Zhang Z et al. 3,3´-Diindolylmethane decreases VCAM-1 expression and alleviates experimental colitis via a BRCA1-dependent antioxidant pathway. Free Radic. Biol. Med.50(2), 228–236 (2011).
   PubMed Web of Science ®Google Scholar
• Darvesh AS, Carroll RT, Bishayee A et al. Oxidative stress and Alzheimer’s disease: dietary polyphenols as potential therapeutic agents. Expert Rev. Neurother.10(5), 729–745 (2010).
   PubMed Web of Science ®Google Scholar
• Gollücke AP. Recent applications of grape polyphenols in foods, beverages and supplements. Recent Pat. Food Nutr. Agric.2(2), 105–109 (2010).
   PubMedGoogle Scholar
• de la Iglesia R, Milagro FI, Campión J et al. Healthy properties of proanthocyanidins. Biofactors36(3), 159–168 (2010).
   PubMed Web of Science ®Google Scholar
• Es-Safi NE, Ghidouche S, Ducrot PH. Flavonoids: hemisynthesis, reactivity, characterization and free radical scavenging activity. Molecules12(9), 2228–2258 (2007).
   PubMed Web of Science ®Google Scholar
• Ferrières J. The French paradox: lessons for other countries. Heart90(1), 107–111 (2004).
   PubMed Web of Science ®Google Scholar
• Ramprasath VR, Jones PJ. Anti-atherogenic effects of resveratrol. Eur. J. Clin. Nutr.64(7), 660–668 (2010).
   PubMed Web of Science ®Google Scholar
• Shao C, Chen L, Lu C, Shen CL, Gao W. A gel-based proteomic analysis of the effects of green tea polyphenols on ovariectomized rats. Nutrition27(6), 681–686 (2010).
   PubMed Web of Science ®Google Scholar
• Badawoud MH, Al-Saggaf SM, Hagrasi MM. The effect of green tea on the oxidative stress and blood glucose level of diabetic rats. Med. Sci.14(3), 3–11 (2007).
   Google Scholar
• Pavlik VN, Doody RS, Rountree SD, Darby EJ. Vitamin E use is associated with improved survival in an Alzheimer’s disease cohort. Dement. Geriatr. Cogn. Disord.28(6), 536–540 (2009).
   PubMed Web of Science ®Google Scholar
• Binfaré RW, Rosa AO, Lobato KR et al. Ascorbic acid administration produces an antidepressant-like effect: evidence for the involvement of monoaminergic neurotransmission. Prog. Neuropsychopharmacol. Biol. Psychiatry.33(3), 530–540 (2009).
   PubMed Web of Science ®Google Scholar
• Skarupski KA, Tangney C, Li H et al. Longitudinal association of vitamin B-6, folate, and vitamin B-12 with depressive symptoms among older adults over time. Am. J. Clin. Nutr.92(2), 330–335 (2010).
   PubMed Web of Science ®Google Scholar
• Endo N, Nishiyama K, Otsuka A et al. Antioxidant activity of vitamin B6 delays homocysteine-induced atherosclerosis in rats. Br. J. Nutr.95(6), 1088–1093 (2006).
   PubMed Web of Science ®Google Scholar
• Pravst I, Zmitek K, Zmitek J. Coenzyme Q10 contents in foods and fortification strategies. Crit. Rev. Food Sci. Nutr.50(4), 269–280 (2010).
   PubMed Web of Science ®Google Scholar
• Molyneux SL, Young JM, Florkowski CM et al. Coenzyme Q10: is there a clinical role and a case for measurement? Clin. Biochem. Rev.29(2), 71–82 (2008).
   PubMedGoogle Scholar
• Linnane AW, Kios M, Vitetta L. The essential requirement for superoxide radical and nitric oxide formation for normal physiological function and healthy aging. Mitochondrion7(1–2), 1–5 (2007).
   PubMed Web of Science ®Google Scholar
• Granados-Principal S, Quiles JL, Ramirez-Tortosa CL et al. New advances in molecular mechanisms and the prevention of adriamycin toxicity by antioxidant nutrients. Food Chem. Toxicol.48(6), 1425–1438 (2010).
   PubMed Web of Science ®Google Scholar
• Ramos AA, Azqueta A, Pereira-Wilson C, Collins AR. Polyphenolic compounds from Salvia species protect cellular DNA from oxidation and stimulate DNA repair in cultured human cells. J. Agric. Food Chem.58(12), 7465–7471 (2010).
   PubMed Web of Science ®Google Scholar
• Georgiev M, Abrashev R, Krumova E et al. Rosmarinic acid and antioxidant enzyme activities in Lavandula vera MM cell suspension culture: a comparative study. Appl. Biochem. Biotechnol.159(2), 415–425 (2009).
   PubMed Web of Science ®Google Scholar
• Song W, Derito CM, Liu MK et al. Cellular antioxidant activity of common vegetables. J. Agric. Food Chem.58(11), 6621–6629 (2010).
   PubMed Web of Science ®Google Scholar
• Kuriakose GC, Kurup MG. Evaluation of renoprotective effect of Aphanizomenon flos-aquae on cisplatin-induced renal dysfunction in rats. Ren. Fail.30(7), 717–725 (2008).
   PubMed Web of Science ®Google Scholar
• de la Lastra CA, Villegas I. Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem. Soc. Trans.35(5), 1156–1160 (2007).
   PubMed Web of Science ®Google Scholar
• Azam S, Hadi N, Khan NU, Hadi SM. Prooxidant property of green tea polyphenols epicatechin and epigallocatechin-3-gallate: implications for anticancer properties. Toxicol. In Vitro18(5), 555–561 (2004).
   PubMed Web of Science ®Google Scholar
• Lozano-Sánchez J, Segura-Carretero A, Menendez JA et al. Prediction of extra virgin olive oil varieties through their phenolic profile. potential cytotoxic activity againstm human breast cancer cells. J. Agric. Food Chem.58(18), 9942–9955 (2010).
   PubMed Web of Science ®Google Scholar
• Conklin KA. Dietary polyunsaturated fatty acids: impact on cancer chemotherapy and radiation. Altern. Med. Rev.7(1), 4–21 (2002).
   PubMedGoogle Scholar
• Aquilano K, Filomeni G, Baldelli S et al. Neuronal nitric oxide synthase protects neuroblastoma cells from oxidative stress mediated by garlic derivatives. J. Neurochem.101(5), 1327–1337 (2007).
   PubMed Web of Science ®Google Scholar
• Nair S, Hebbar V, Shen G et al. Synergistic effects of a combination of dietary factors sulforaphane and (-) epigallocatechin-3-gallate in HT-29 AP-1 human colon carcinoma cells. Pharm. Res.25(2), 387–399 (2008).
   PubMed Web of Science ®Google Scholar
• Ju J, Picinich SC, Yang Z et al. Cancer-preventive activities of tocopherols and tocotrienols. Carcinogenesis31(4), 533–542 (2010).
   PubMed Web of Science ®Google Scholar
• Bar-Sela G, Epelbaum R, Schaffer M. Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications. Curr. Med. Chem.17(3), 190–197 (2010).
   PubMed Web of Science ®Google Scholar
• Marlowe C. The Tragedy of Dido, Queen of Carthage. In: The Works of Christopher Marlowe. Kessinger Publishing Co., MT, USA, 174 (2004).
   Google Scholar
• Alighieri D. Inferno [Hell] Canto. In: The Divine Comedy. The Harvard Classics, MA, USA, XXVI (1909).
   Google Scholar
• Koster MP, Pennings JL, Imholz S et al. Proteomics and Down syndrome screening: a validation study. Prenat. Diagn.30(11), 1039–1043 (2010).
   PubMed Web of Science ®Google Scholar